Helicobacter Pylori and Proton Pump Inhibitor

• Status: Completed
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to know the distribution of HP in stomach before use of PPI, during use of PPI, and after stop of PPI.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Asan Medical Center
• Treatments: Dexlansoprazole; Lansoprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole

Criteria

Inclusion Criteria:

1. Patients who are indicated to endoscopic resection due to gastric neoplasm

2. Aged between 19 to 65 years

3. Informed consent

Exclusion Criteria:

1. Previous history of HP eradication

2. Previous history of PPI use within 6 months

3. No HP infection